Veerkrupa Jewellers Limited (VEERKRUPA.BO)
INR 1.49
(-1.97%)
INR 1.49
(-1.97%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 83 Thousand | -87.84 Million | -3.31 Million | 401.69 Thousand | -43.41 Million | -4.86 Million |
| Net Income | 2.43 Million | 411 Thousand | 90.87 Thousand | 106.77 Thousand | 71 Thousand | 827 Thousand |
| Depreciation & Amortization | 176 Thousand | 146 Thousand | 180.6 Thousand | 229.47 Thousand | 67 Thousand | 40 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.71 Million | -88.46 Million | -3.58 Million | 20.43 Thousand | -46.54 Million | -6.75 Million |
| Other non-cash items | -7.24 Million | 59 Thousand | -1.00 | 45 Thousand | 2.99 Million | 1.02 Million |
| Investing Cash Flow | 880 Thousand | -125 Thousand | -134.7 Thousand | 886.39 Thousand | -417 Thousand | 1.94 Million |
| Investments in PPE | -299 Thousand | -135 Thousand | -134.7 Thousand | - | -417 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.17 Million | 10 Thousand | - | 886.39 Thousand | - | 1.94 Million |
| Financing Cash Flow | 7.94 Million | 88.06 Million | 4.2 Million | - | 48.9 Million | 2.93 Million |
| Debt repayment | - | - | - | - | - | -1.7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 7.94 Million | 88.06 Million | 4.2 Million | - | 48.9 Million | 1.23 Million |
| Accounts receivables | 8.31 Million | -45.06 Million | 24.92 Million | 15.63 Million | -12.56 Million | 120 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -45.79 Million | -21.67 Million | 38.93 Million | -33.37 Million | -7.09 Million |
| Other working capital | -3.59 Million | -43.39 Million | -6.83 Million | -54.55 Million | -599 Thousand | 222 Thousand |
| Cash at beginning of period | 1.25 Million | 1.15 Million | 1.96 Million | 5.07 Million | 218 Thousand | - |
| Cash at end of period | 10.16 Million | 1.25 Million | 1.15 Million | 1.96 Million | 5.07 Million | 218 Thousand |
| Capital Expenditure | -299 Thousand | -135 Thousand | -134.7 Thousand | - | -417 Thousand | - |
| Effect of forex changes on cash | - | - | -1.56 Million | - | -218 Thousand | 193 Thousand |
| Net cash flow / Change in cash | 8.91 Million | 95.8 Thousand | -811.75 Thousand | -3.1 Million | 4.85 Million | 218 Thousand |
| Free Cash Flow | -216 Thousand | -87.98 Million | -3.44 Million | 401.69 Thousand | -43.82 Million | -4.86 Million |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 887.5 Thousand | 887.5 Thousand | 330.5 Thousand | 330.5 Thousand | 183.78 Thousand | 410.56 Thousand |
| Depreciation & Amortization | 88 Thousand | 88 Thousand | - | - | 73.15 Thousand | 146.3 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.15 Million | -4.15 Million | 6.5 Million | 6.5 Million | -15.29 Million | -88.46 Million |
| Other non-cash items | -4.46 Million | -4.46 Million | 845.5 Thousand | 845.5 Thousand | -30.19 Million | 69.29 Thousand |
| Investing Cash Flow | 77.5 Thousand | 77.5 Thousand | 362.5 Thousand | 362.5 Thousand | -24.85 Thousand | -134.7 Thousand |
| Investments in PPE | -149.5 Thousand | -149.5 Thousand | - | - | -64.85 Thousand | -134.7 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 227 Thousand | 227 Thousand | 362.5 Thousand | 362.5 Thousand | 39.99 Thousand | - |
| Financing Cash Flow | 8.68 Million | 8.68 Million | -4.71 Million | -4.71 Million | 44.77 Million | 88.06 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 8.68 Million | 8.68 Million | -4.71 Million | -4.71 Million | 44.77 Million | 88.06 Million |
| Accounts receivables | 9.48 Million | 9.48 Million | -5.33 Million | -5.33 Million | 273.19 Thousand | 722.39 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -12.41 Million | -12.41 Million | 12.41 Million | 12.41 Million | 4.9 Million | -45.79 Million |
| Other working capital | -1.21 Million | -1.21 Million | -577.5 Thousand | -577.5 Thousand | -20.46 Million | -43.39 Million |
| Cash at beginning of period | - | - | - | - | - | 1.15 Million |
| Cash at end of period | 1.12 Million | 1.12 Million | 3.33 Million | 3.33 Million | -482.59 Thousand | 1.25 Million |
| Capital Expenditure | -149.5 Thousand | -149.5 Thousand | - | - | -64.85 Thousand | -134.7 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.12 Million | 1.12 Million | 3.33 Million | 3.33 Million | -482.59 Thousand | 95.81 Thousand |
| Free Cash Flow | -7.79 Million | -7.79 Million | 7.68 Million | 7.68 Million | -45.29 Million | -87.97 Million |
OROSMITHS
IONAF
GSK
ESBA
KESAR
LRE